Skip to main content
. 2014 Mar 1;73(5):895–901. doi: 10.1007/s00280-014-2418-8

Table 2.

Patients characteristics (N=12)

Age
 Median 56
 Range 40–65
PS
 0 11
 1 1
FIOG stage
 I 2
 II 1
 III 8
 IV 1
Histological type
 Serous 8
 Mucinus 0
 Clear cell 3
 Endometrioid 1
Previous regimens
 1 4
 2 3
 3≤ 5
Last regimen
 TC 8
 TP 1
 DP 1
 CDDP/VP16 1
 PTX 1

TC paclitaxel/carboplatin, TP paclitaxel/cisplatin, DP docetaxel/cisplatin, CDDP cisplatin, PTX paclitaxel